BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 5131401)

  • 21. Liver disease in ulcerative colitis.
    Lancet; 1970 Aug; 2(7669):402-3. PubMed ID: 4194697
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating B and T lymphocytes in chronic active liver disease.
    Fehér J; Jakab L; Pozsonyi T; Papp G
    Acta Med Acad Sci Hung; 1978; 35(1):47-52. PubMed ID: 310622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complement activity in chronic liver diseases].
    Ghidini O; Del Campo A; Tomasi A; Franzoni A
    G Clin Med; 1970 Jul; 51(7):568-79. PubMed ID: 5527274
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Walls WD; Losowsky MS
    Thromb Diath Haemorrh; 1969 Feb; 21(1):134-43. PubMed ID: 5773724
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sodium, potassium].
    Ueno Y; Ogino Y; Kinouchi T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():250-6. PubMed ID: 15658312
    [No Abstract]   [Full Text] [Related]  

  • 26. LP-X in cholestasis.
    Tanno H; Fay O; Palazzi J; Pedrana R; Yäger E; Roncoroni M
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):289-91. PubMed ID: 173123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantitative immunological blood protein studies in liver diseases].
    Müller HE; Müller-von Voigt I
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Sep; 133(4):366-75. PubMed ID: 4173553
    [No Abstract]   [Full Text] [Related]  

  • 28. [Guanine deaminase or guanase, the enzyme of hepatic cytolysis. Its diagnostic value in 500 patients].
    Bel A; Dietsch R; Alary R; Savoye B; Levrat R; Nesmoz J; Nyssen M
    Presse Med (1893); 1970 Feb; 78(11):495-9. PubMed ID: 5418623
    [No Abstract]   [Full Text] [Related]  

  • 29. [Data on hepatitis antigen (HAA)].
    Renger F; Reimann W; Frank J; Kobe E; Vogel C; Vogel H; Kayser W; Bosse W; Geyer F
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(1):83-6. PubMed ID: 4347640
    [No Abstract]   [Full Text] [Related]  

  • 30. [Electrolyte changes in the plasma, erythrocytes, and in the skeletal muscle in patients with chronic liver diseases].
    Groh J; Bartos V; Kvasnicka J; Erben J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(2):Suppl:225-62. PubMed ID: 5253950
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantification of individual serum bile acids in patients with liver diseases using high-performance liquid chromatography.
    Okuda H; Obata H; Nakanishi T; Hisamitsu T; Matsubara K; Watanabe H
    Hepatogastroenterology; 1984 Aug; 31(4):168-71. PubMed ID: 6479837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of an original synthetic choleretic: 3,4-methylenedioxycinnamic acid].
    Tacca GP
    Minerva Gastroenterol; 1974; 20(4):168-74. PubMed ID: 4459733
    [No Abstract]   [Full Text] [Related]  

  • 33. [Discriminatory function of serum proteins in liver and biliary tract diseases].
    Nilius R; Zipprich B; Otto L; Busse HJ
    Z Gesamte Inn Med; 1977 Jun; 32(12):265-70. PubMed ID: 910527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic sarcoidosis. Clinicopathologic features in 100 patients.
    Devaney K; Goodman ZD; Epstein MS; Zimmerman HJ; Ishak KG
    Am J Surg Pathol; 1993 Dec; 17(12):1272-80. PubMed ID: 8238735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of liver function by means of the glucagon test].
    Brunner H; Grabner G; Michalek P; Paumgartner G
    Wien Z Inn Med; 1968; 49(11):409-17. PubMed ID: 5737590
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute and chronic cerebrovascular insufficiency in patients with diseases of the hepato-cholecysto-pancreatic system].
    Bogolepov NK; Martynov IuS; Malkova EV; Kuznetsov VN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(2):210-20. PubMed ID: 5572062
    [No Abstract]   [Full Text] [Related]  

  • 37. [Significance of various diagnostic parameters in chronic liver diseases].
    Heinicke HJ
    Z Gesamte Inn Med; 1973 Feb; 28(4):93-101. PubMed ID: 4540734
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatitis virus B infection in chronic diffuse liver diseases].
    Dávid K; Halmy L
    Orv Hetil; 1980 Mar; 121(9):501-4. PubMed ID: 7375108
    [No Abstract]   [Full Text] [Related]  

  • 39. [The angiotensinase activity of -L-asparaginyl aminopeptidase in the serum of normal subjects, in patients with hepatobiliary diseases and during pregnancy].
    Kaulhausen H; Pfeiffer P; Breuer H
    Z Klin Chem Klin Biochem; 1972 Feb; 10(2):51-5. PubMed ID: 4347073
    [No Abstract]   [Full Text] [Related]  

  • 40. [Analysis of serum lipoproteins and its clinical significance].
    Kizaki H; Koto A; Matsuzaki M; Takeuchi I; Onizuka T
    Seishin Igaku Kenkyusho Gyosekishu; 1970; 17():25-33. PubMed ID: 5512898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.